European Society of Surgical Oncology (ESSO) is a prominent organization dedicated to advancing the science and practice of cancer surgery for the benefit of patients. Since its establishment in 1981, ESSO has grown into a community of over 16,000 surgical oncologists worldwide, ensuring the highest standard of surgical treatment for European cancer patients. ESSO's impactful initiatives include its annual Congress, educational activities, quality assurance projects, and the esteemed scientific journal EJSO - The Journal of Cancer Surgery.
With a focus on Education and Health Care, ESSO stands at the forefront of fostering progress in surgical oncology, contributing to the continuous improvement of cancer treatment quality, accessibility, and innovation. Its dedication to sharing state-of-the-art knowledge and expertise for over 35 years underscores its commitment to advancing the field.
ESSO's headquarters in Belgium serves as a base for its global reach, supporting its members in their mission to elevate cancer surgery to new heights. As of now, there is no publicly available information regarding the organization's recent investments or investors.
With its established presence, commitment to excellence, and global impact, ESSO remains a vital force in the ongoing advancement of surgical oncology, benefitting patients and healthcare professionals alike.
There is no investment information
No recent news or press coverage available for European Society of Surgical Oncology (ESSO).